KBI Biopharma Recognized as a Leader in All Six Categories of the 2024 CDMO Leadership Awards
KBI Biopharma, a JSR Life Sciences Company and leading global Contract Development and Manufacturing Organization (CDMO) has received six awards in...
KBI Biopharma, a JSR Life Sciences Company and leading global Contract Development and Manufacturing Organization (CDMO) has received six awards in...
Alliance combines strengths of both companies resulting in end-to-end offering for efficient and seamless biopharmaceutical development and cGMP...
Durham, North Carolina (December 5, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the recent appointment of Maggie...
Offering extends legacy of SUREtechnology Platform™ for more efficient workflows and simplified processes. Durham, North Carolina (September 12,...
Durham, North Carolina (August 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments...
KBI's PUREplatform™ is a game-changing microbial expression offering that redefines biopharmaceutical manufacturing. The platform leverages the...
The recent operational consolidation of KBI Biopharma, Inc. and Selexis SA brings a streamlined approach to support customers in rapidly accelerating...
Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes...
KBI’s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers Sunnyvale,...
Durham, North Carolina (May 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the appointment of Marykay...
Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.